PriceTargets.com logo

cbdMD - YCBD Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $3.00
  • Forecasted Upside: 233.33%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.90 As of 04/24/2024 01:00 AM ET
▼ -0.01 (-1.10%)

This chart shows the closing price for YCBD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New cbdMD Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YCBD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YCBD

Analyst Price Target is $3.00
▲ +233.33% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for cbdMD in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 233.33% upside from the last price of $0.90.

This chart shows the closing price for YCBD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in cbdMD. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/1/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/5/2023Maxim GroupInitiated CoverageBuy$3.00
6/18/2021Cantor FitzgeraldReiterated RatingNeutral$184.50 ➝ $146.25
1/29/2021Cantor FitzgeraldBoost TargetNeutral$162.00 ➝ $193.50
12/8/2020Cantor FitzgeraldReiterated RatingNeutral
9/9/2020BenchmarkBoost TargetSpeculative Buy$135.00 ➝ $180.00
8/13/2020Cantor FitzgeraldBoost TargetNeutral$81.00 ➝ $162.00
5/18/2020Cantor FitzgeraldBoost TargetNeutral$54.00 ➝ $81.00
3/9/2020Cantor FitzgeraldBoost TargetNeutral$54.00 ➝ $153.00
12/19/2019BenchmarkLower TargetSpeculative Buy$405.00 ➝ $315.00
11/8/2019Cantor FitzgeraldReiterated RatingNeutral
11/7/2019Cantor FitzgeraldInitiated CoverageNeutral
9/10/2019BenchmarkInitiated CoverageBuy$405.00
(Data available from 4/24/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/27/2023
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2023
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2024
  • 4 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/24/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
cbdMD logo
cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.
Read More

Today's Range

Now: $0.90
Low: $0.87
High: $0.95

50 Day Range

MA: N/A

52 Week Range

Now: $0.90
Low: $0.56
High: $6.25

Volume

28,580 shs

Average Volume

261,620 shs

Market Capitalization

$2.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.15

Frequently Asked Questions

What sell-side analysts currently cover shares of cbdMD?

The following sell-side analysts have issued reports on cbdMD in the last twelve months: Maxim Group.
View the latest analyst ratings for YCBD.

What is the current price target for cbdMD?

1 Wall Street analysts have set twelve-month price targets for cbdMD in the last year. Their average twelve-month price target is $3.00, suggesting a possible upside of 237.1%. Maxim Group has the highest price target set, predicting YCBD will reach $3.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $3.00 for cbdMD in the next year.
View the latest price targets for YCBD.

What is the current consensus analyst rating for cbdMD?

cbdMD currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe YCBD will outperform the market and that investors should add to their positions of cbdMD.
View the latest ratings for YCBD.

What other companies compete with cbdMD?

Other companies that are similar to cbdMD include Saddle Ranch Media, Leafbuyer Technologies, Lytus Technologies Holdings PTV., Netcapital and FOXO Technologies. Learn More about companies similar to cbdMD.

How do I contact cbdMD's investor relations team?

cbdMD's physical mailing address is 8845 Red Oak Boulevard, Charlotte NC, 28217. The company's listed phone number is (704) 445-3060 and its investor relations email address is [email protected]. The official website for cbdMD is www.cbdmd.com. Learn More about contacing cbdMD investor relations.